Nanomedicine-Based Gene Delivery for a Truncated Tumor Suppressor RB94 Promotes Lung Cancer Immunity

SIMPLE SUMMARY: Advanced therapies have provided substantial clinical benefits in oncology, but low response rates in lung cancer patients remain challenging. Using preclinical models of human lung cancer, we investigated the anti-tumor potency of nanomedicine-based gene delivery for the tumor suppr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sang-Soo, Doherty, Caroline, Moghe, Manish, Rait, Antonina, Pirollo, Kathleen F., Harford, Joe B., Chang, Esther H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600612/
https://www.ncbi.nlm.nih.gov/pubmed/36291878
http://dx.doi.org/10.3390/cancers14205092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600612/
https://www.ncbi.nlm.nih.gov/pubmed/36291878
http://dx.doi.org/10.3390/cancers14205092

Ejemplares similares